Mammalian target of rapamycin (mTOR) inhibitors could be associated with acute nephrotoxicity, according to French researchers. The team describes 4 cancer patients who developed severe acute kidney ...

The search for a better biomarker than creatine for acute kidney injury (AKI) has been “long and elusive.” However, could researchers be on the right path now? “The thinking is moving away from trying ...

Cancer therapies can trigger diverse kidney pathologies, so kidney biopsy is critical for management, according to investigators. Kidney biopsy should be considered in every patient who develops ...

There is great value, both for clinical trials and clinical practice, in biomarkers that identify patients at greatest risk of developing chronic kidney disease (CKD) after acute kidney injury, ...